Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Adaptive Biotechnologies a Buy?

TheMotleyFool

0 0

Is Adaptive Biotechnologies a Buy?Photo, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

There's nothing like a viral pandemic to remind investors how important it is to understand the human immune system. Shares of Adaptive Biotechnologies (NASDAQ: ADPT) soared when the biotech took steps to address the coronavirus pandemic and partnered with Amgen (NASDAQ: AMGN) and Microsoft (NASDAQ: MSFT) in the process.

Earlier this year, an enthusiastic market more than doubled the price of Adaptive Biotechnologies stock. Now that shares are trading around 22% below their recent peak, investors are wondering if it's a good time to buy.

Image source: Getty Images.

Source Fool.com

Like: 0

ADPT

Teilen